• PCR65 Diagnostic Odyssey of Patients With the Rare Immunodeficiency-Activated PI3 Kinase Delta Syndrome (APDS): Case Study With Expert Interviews and Patient Surveys

    Dec 1, 2025, 00:00

  • MT1 A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices

    Dec 1, 2025, 00:00

  • Physician-Directed Reinvestment: A Novel Cost-Savings Framework for Hospital Systems That Leverages Frontline Physicians

    Dec 1, 2025, 00:00

  • EE697 The Disease Burden of Systemic Sclerosis in the Russian Federation

    Dec 1, 2025, 00:00

  • EE250 Cost-Effectiveness of Familial Hypercholesterolemia Cascade Testing in Thailand: A Comparative Analysis of Exome vs. Long-Read DNA Sequencing

    Dec 1, 2025, 00:00

  • EPH47 Colorectal Cancer Mortality Overview in Mexico 1998-2023

    Dec 1, 2025, 00:00

  • HSD98 Real-World Treatment Patterns of US Patients With Platinum-Resistant Ovarian Cancer

    Dec 1, 2025, 00:00

  • MSR12 Accounting for the Additional Uncertainty Following Rank-Preserving Structural Failure Time Model (RPSFTM) Crossover Adjustment in Survival Analysis: A Sage Approach

    Dec 1, 2025, 00:00

  • MSR146 Metamodels SHAP Analysis: Unearthing Data Interactions

    Dec 1, 2025, 00:00

  • RWD30 Characteristics of Real-World Data Landscape in Spain: A Scoping Review

    Dec 1, 2025, 00:00

  • PCR196 Psychometric Performance of EQ-HWB for Japanese Populations

    Dec 1, 2025, 00:00

  • P41 Cost-Effectiveness Modeling of CAR-T Cell Therapies in Hematologic Malignancies: Insights From NICE and CDA-AMC Appraisals

    Dec 1, 2025, 00:00

  • ISPOR Europe 2025: Powering Value and Access Through Patient-Centered Collaboration

    Dec 1, 2025, 00:00

  • PCR266 We Hear What You Are Saying: The Development and Design of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centered Outcomes Research Studies

    Dec 1, 2025, 00:00

  • EE586 Modeled Number and Cost of Biparametric Magnetic Resonance Imaging (bpMRI) Examinations in a Nationwide Prostate Cancer Screening Program: Utilizing the Results of the Czech Prostapilot Study

    Dec 1, 2025, 00:00

  • CO235 The Clinical and Economic Impact of the Introduction of Emicizumab as Prophylactic Treatment for Hemophilia A Patients in Greece

    Dec 1, 2025, 00:00

  • EPH75 Epidemiological Characteristics and Economic Burden of IgA Nephropathy—a Retrospective Study Using Multicenter Electronic Medical Records Data in China

    Dec 1, 2025, 00:00

  • HTA77 Comparative Analysis of Economic Evaluation Frameworks for AI-Based Digital Health Technologies Across Four HTA Systems

    Dec 1, 2025, 00:00

  • PCR265 Wasfaty Improves Quality of Outpatient Pharmaceutical Service at a Tertiary Academic Hospital: A Descriptive Analysis

    Dec 1, 2025, 00:00

  • PCR95 Exploring the Use and Perception of Patient-Reported Outcome Evidence Among Cardiologists and Patients With Heart Failure

    Dec 1, 2025, 00:00

  • EE599 Optimization of the EVAR Pathway: An Integrated Organizational Model for Clinical Efficiency and Economic Sustainability

    Dec 1, 2025, 00:00

  • HSD51 From Admission to Discharge: Understanding the Transplant Patient Journey With German Statutory Health Insurance Claims Data

    Dec 1, 2025, 00:00

  • HPR70 ESMO-MCBS Evaluation and French Derogatory Access Decision: Is There a Correlation?

    Dec 1, 2025, 00:00

  • EE632 Quantifying the Value of Information in Early Stage Health Technology Assessment: Guiding Investment in Evidence Generation

    Dec 1, 2025, 00:00

  • MSR224 Which Generative AI Method Is Used for High Specificity? A Methodological Comparison From the Systemic Literature Review of the Burden of Influenza in France

    Dec 1, 2025, 00:00

  • EE471 Financing Sustainable Public Health: Design of a Herpes Zoster Prevention Bond to Fund Vaccination

    Dec 1, 2025, 00:00

  • RWD109 Integrating Mendelian Randomization With Real-World Eviden Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries

    Dec 1, 2025, 00:00

  • HPR40 Building Risk-Sharing Agreements in Chile: Feasibility and Policy Options

    Dec 1, 2025, 00:00

  • CO158 Leveraging Generative AI for Efficient Patient Safety Narrative Drafting: A Semaglutide Case Study

    Dec 1, 2025, 00:00

  • HTA153 From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe

    Dec 1, 2025, 00:00

  • RWD182 Transforming Patient Journeys With Agentic AI

    Dec 1, 2025, 00:00

  • EE344 Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country

    Dec 1, 2025, 00:00

  • EE631 Quantifying the Societal Value: Reduced Burden and Resource Savings From Baloxavir Marboxil's Influenza Transmission Protection in China

    Dec 1, 2025, 00:00

  • HTA118 Early Health Technology Assessment and Cost-Effectiveness of the National Cardiovascular Disease Prevention Program in Greece

    Dec 1, 2025, 00:00

  • EE103 Budget Impact of a Minimally Invasive Surgical Treatment for Benign Prostatic Obstruction in Italian Healthcare Service

    Dec 1, 2025, 00:00

  • MSR70 Development and Assessment of a Portability Strategy for Computable Operational Definitions

    Dec 1, 2025, 00:00

  • HSD115 Treatment Patterns for Unresectable Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative and Triple-Negative Breast Cancers in France

    Dec 1, 2025, 00:00

  • MT14 Digital Therapeutics in Europe: A Structured Review of Reimbursement and Access Pathways

    Dec 1, 2025, 00:00

  • CO217 Safety Profile of Semaglutide in Obesity Management With or Without Type 2 Diabetes (T2DM): A Systematic Literature Review From Controlled and Real-World Settings

    Dec 1, 2025, 00:00

  • HPR133 Longitudinal Trends in Biosimilar Uptake in France 2019-2024: Insights by Dispensing Pathway and Prescribing Origin

    Dec 1, 2025, 00:00

  • HSD62 Improving Patient Flow and Multidisciplinary Coordination in Urothelial Carcinoma: Insights From Bulgarian Oncologists

    Dec 1, 2025, 00:00

  • EE243 Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden

    Dec 1, 2025, 00:00

  • HPR174 Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures

    Dec 1, 2025, 00:00

  • EPH165 Monitoring the Burden of Lung Cancer in Germany: Trends in Incidence and Survival Using ZfKD Registry Data 2020-2023

    Dec 1, 2025, 00:00

  • MSR44 Balancing Power and Interpretation: Responder Analysis vs. Mean Differences for PRO Endpoints in Oncology Clinical Trials

    Dec 1, 2025, 00:00

  • PCR3 A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Among Adolescents Aged 10-18 in China

    Dec 1, 2025, 00:00

  • HPR206 The Innovative Licensing and Access Pathway (ILAP): Early Pathway Experience, Examining, Process Adaptations, and Industry Impact

    Dec 1, 2025, 00:00

  • EE119 Burden of Schizophrenia on the Brazilian Public Healthcare System: A Cost and Service Analysis

    Dec 1, 2025, 00:00

  • HSD4 Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK

    Dec 1, 2025, 00:00

  • RWD105 Inducing Labor in Denmark: A Descriptive Study

    Dec 1, 2025, 00:00

  • EPH229 The Burden of Patients With Severe Asthma: A Comparison Between Patients Treated With and Eligible for Monoclonal Antibodies Through a Retrospective Observational Analysis of Italian Real-World Data

    Dec 1, 2025, 00:00

  • MT41 The Role of Flexible Cysto-Nephroscope in Enhancing Stone-Free Rates of Percutaneous Nephrolithotomy: A Global Survey

    Dec 1, 2025, 00:00

  • HTA62 Budgetary Impact of Ultra-Rare Diseases in Brazil: A Review of Decisions From the Past Five Years

    Dec 1, 2025, 00:00

  • HTA19 Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child

    Dec 1, 2025, 00:00

  • EE687 The Budget Impact and Time Savings of Introducing Subcutaneously Administered Nivolumab and Hyaluronidase (NIVO SC) to Patients Receiving Intravenously Administered Nivolumab (NIVO IV) Across Indications in Canada

    Dec 1, 2025, 00:00

  • EE301 Cost-Utility Analysis Of Erdosteine for the Prevention of Exacerbations in Patients With COPD in the Czech Republic

    Dec 1, 2025, 00:00

  • MSR82 Efficacy and Safety of Modern Biologics Compared to Conventional Therapies in AQP-4 Positive Neuromyelitis Optica Spectrum Disorder: A Fully AI-Automated Targeted Literature Review

    Dec 1, 2025, 00:00

  • EE350 Economic and Clinical Impact of Older Adult Vaccination With the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico

    Dec 1, 2025, 00:00

  • EE523 Human Metapneumovirus (hMPV): Systematic Literature Review of Economic and Humanistic Disease Burden in Adults

    Dec 1, 2025, 00:00

  • EE57 Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants

    Dec 1, 2025, 00:00

  • PT6 Real-World Effectiveness, Safety Economic Impact, and Humanistic Outcomes of Bispecific Antibodies (BsAbs) in Third-or-Later-Line (3L+) Treatment of Relapsed/Refractory (R/R) Large B-cell Lymphoma (LBCL): A Systematic Review and Meta-An ...

    Dec 1, 2025, 00:00

  • EPH26 The Impact of Menopausal Hormone Therapy on Productivity and Health Care Utilization in Women: A Finnish Claims Database Study

    Dec 1, 2025, 00:00

  • PCR108 Health State Utilities Associated With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

    Dec 1, 2025, 00:00

  • RWD190 Use of RWE in HTA Submissions: A Systematic Review of Case Studies Across Three HTA Agencies Reveals Continued Concerns Around Internal Validity and Unmeasured Confounding

    Dec 1, 2025, 00:00

  • EE717 The Long-Term Cost-Effectiveness of Insulin Icodec vs. Once-Daily Basal Insulin Analogs in Italy

    Dec 1, 2025, 00:00

  • EE578 Microcosting Analysis of Oral, Subcutaneous, and Intravenous Second-line Multiple Sclerosis Treatments Administered at Home or in Hospital

    Dec 1, 2025, 00:00

  • MSR23 Ai-Augmented Data Extraction in Literature Reviews: Toward First-Pass Accuracy Competitive With Human Performance

    Dec 1, 2025, 00:00

  • EE178 Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in Brazil

    Dec 1, 2025, 00:00

  • HTA178 How Do National Systems Take the JCA Into Account Navigating Specificities to Achieve Accelerated Patient Access?

    Dec 1, 2025, 00:00

  • RWD66 Disease Severity at Advanced Therapy Initiation in Real-World Psoriasis Patients in the US

    Dec 1, 2025, 00:00

  • EPH38 Care of Patients With Phenylketonuria (PKU) in Germany a Claims Data Analysis From 2013 to 2023

    Dec 1, 2025, 00:00

  • MSR178 Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset

    Dec 1, 2025, 00:00

  • EE246 Cost-Effectiveness of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer Alongside the LIBELULE Randomized Phase III Trial

    Dec 1, 2025, 00:00

  • EE618 Productivity and Cost-Effectiveness of Initiative for Decentralized Cancer Care in Region Uppsala, Sweden

    Dec 1, 2025, 00:00

  • CO186 Preliminary Real-World Results of a Community Pharmacy-Based Intervention in COPD: Evidence From the Chronic Diseases From A to Z Program

    Dec 1, 2025, 00:00

  • PCR71 English Translation, Cross-Cultural Adaptation and Validation of the French New Patient-Reported Outcome Measures of the Multiple Sclerosis Autonomy Scale (MSAS)

    Dec 1, 2025, 00:00

  • RWD92 Healthcare Resource Use and Mortality After Diabetic Ketoacidosis: Insights From Linked Primary- and Secondary-Care Data in the UK

    Dec 1, 2025, 00:00

  • EE727 The Socioeconomic Value of Adult Respiratory Immunization Programs in Spain: How Much Can We Gain From Expanding Prevention Efforts?

    Dec 1, 2025, 00:00

  • HPR63 Does the Joint Clinical Assessment (JCA) Enable Health Equity Across Europe? A Review of HTA Practices in the EU

    Dec 1, 2025, 00:00

  • HTA1 Inefficiencies in Developing UK and Irish HTA Submissions and How to Streamline the Process

    Dec 1, 2025, 00:00

  • EPH213 Sex Differences in Autoimmune Multimorbidity Across 11 Autoimmune Disorders in the Real-World Setting in Germany

    Dec 1, 2025, 00:00

  • EPH243 The Incidence and Survival of HPV-Positive and HPV-Negative Malignant Head and Neck Squamous Cell Carcinoma (HNSCC) in the United States: A Surveillance Epidemiology and End Results SEER 2000-2022 Database Analysis

    Dec 1, 2025, 00:00

  • CO112 Evaluation of Health-Related Quality of Life (HRQoL) Among Patients Treated With Lifileucel After Progression on Immune Checkpoint Inhibitors (ICIs) and Targeted Therapies: Analyses From the C-144-01 Trial

    Dec 1, 2025, 00:00

  • EE269 Cost-Effectiveness of Proton Beam Therapy in the Treatment of Pediatric Medulloblastoma in France

    Dec 1, 2025, 00:00

  • P51 Catalogue of Actions to Address Policy Barriers of Drug Repurposing

    Dec 1, 2025, 00:00

  • EE722 The Role of Unpaid Work in Measuring the Social Costs of Disease

    Dec 1, 2025, 00:00

  • EPH204 Real-life-Persistence to Antifibrotic Treatments in the French Population

    Dec 1, 2025, 00:00

  • EE567 Live Attenuated Influenza Vaccination (LAIV) for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • PT14 The IMPACT Framework: A Value Assessment Framework for Holistic Health Technology Assessment

    Dec 1, 2025, 00:00

  • MSR105 Exploring Perspectives on Adult Pneumococcal Vaccination: A Qualitative Preference Study of Healthcare Providers (HCPs) and Healthcare Consumers (HCCs) in the United Kingdom and Italy

    Dec 1, 2025, 00:00

  • PT5 Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States

    Dec 1, 2025, 00:00

  • EE127 Clinical and Economic Benefits of Extended-Release Metformin In Prediabetes Management

    Dec 1, 2025, 00:00

  • HTA331 The Safety and Effectiveness of Drug-Induced Sleep Endoscopy in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

    Dec 1, 2025, 00:00

  • EPH45 Clinical Profile of Asthma and Its Geographical Variability in Southern Spain

    Dec 1, 2025, 00:00

  • CO81 Economic and Clinical Burden of Diagnosed Congenital Cytomegalovirus Disease in France During the First 2 Years of Life

    Dec 1, 2025, 00:00

  • HSD76 Modeling the Environmental and Cost Impact of a Novel Detergent in NHS Endoscope Reprocessing Workflows

    Dec 1, 2025, 00:00

  • HTA278 Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review

    Dec 1, 2025, 00:00

  • MT15 Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review

    Dec 1, 2025, 00:00

  • RWD13 AI for Precision Oncology Eviden Case Study Research From British Columbia, Canada

    Dec 1, 2025, 00:00

  • MSR139 Long-Term Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST): Investigating a Parametric Survival Model for Extrapolations

    Dec 1, 2025, 00:00

  • HTA131 Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials

    Dec 1, 2025, 00:00

  • EE220 Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in Spain

    Dec 1, 2025, 00:00

  • EE515 Healthcare Resource Utilization and Economic Burden Among Caregivers of Individuals With Autism Spectrum Disorder Caregiver: Findings From the 2024 5EU National Health and Wellness Survey

    Dec 1, 2025, 00:00

  • EE332 Direct Economic Impact of Idiopathic Pulmonary Fibrosis on the Brazilian Private Healthcare System: A Real-World Data Analysis

    Dec 1, 2025, 00:00

  • EPH274 Updated Projections of HPV Vaccine Coverage Growth in Europe: Are Countries on Track to Meet WHO's 2030 Target?

    Dec 1, 2025, 00:00

  • CO206 Real-World Observational Study of PAP Therapy Outcomes in Czech Patients With Sleep Apnea

    Dec 1, 2025, 00:00

  • MSR169 Predicting Outcomes and Estimating Minimum Sample Sizes for Divozilimab Efficacy in NMOSD: A Clinical Trial Simulation and Unanchored Matching-Adjusted Indirect Comparison

    Dec 1, 2025, 00:00

  • CO213 Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review

    Dec 1, 2025, 00:00

  • EE591 Modeling What Matters: The Real-World Burden of Pregnancy-Related Complications in cTTP

    Dec 1, 2025, 00:00

  • RWD132 Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons

    Dec 1, 2025, 00:00

  • EE25 A Novel View on the Treatment Costs of Relapsed or Refractory Diffuse Large B-cell Lymphoma From the Brazilian Private Healthcare System Perspective: A First- to Third-Line Analysis

    Dec 1, 2025, 00:00

  • EPH188 Prevalence and Overlap of Overweight/Obesity Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease in England: A Clinical Practice Research Datalink Study

    Dec 1, 2025, 00:00

  • PCR168 Pain and Fatigue Assessment and Evaluation in Oncology Trials

    Dec 1, 2025, 00:00

  • EPH244 The Incidence, Mortality, and Survival of Breast Cancer per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis

    Dec 1, 2025, 00:00

  • PCR182 Patient-Reported Outcomes After Total Knee Arthroplasty: Comparisons Across TKA Procedures and PRO Domains

    Dec 1, 2025, 00:00

  • EE75 Bimekizumab’s Synergistic Economic Impact Across Four Indications in France

    Dec 1, 2025, 00:00

  • MSR147 Methods for Incidence Progression Estimation in Partitioned Survival Analysis: Does the Chosen Method Matter?

    Dec 1, 2025, 00:00

  • HTA328 The Rise of Optimization in NICE Guidan A Two-Decade Review With a Focus on Prevention

    Dec 1, 2025, 00:00

  • HTA260 Optimizing PICO Scoping in EU HTA: Lessons From a HTA Coordination Group PICO Exercise in Advanced NSCLC to Inform Future Best Practice

    Dec 1, 2025, 00:00

  • CO193 Psychometric Evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL for Vasomotor Symptoms Caused by Endocrine Therapy: Reliability, Validity, and Differential Item Functioning

    Dec 1, 2025, 00:00

  • EPH57 Descriptive Statistics and Polysubstance Use of Pregnant Women Admitted to the United States Treatment Facilities With Methamphetamine Use

    Dec 1, 2025, 00:00

  • MT8 Changes in Medical Technology Availability in Europe Between 2000 and 2020

    Dec 1, 2025, 00:00

  • PCR159 Mental and Behavioral Health Disorders MBHD Among Patients With Metastatic and Nonmetastatic Cancer: A Claims-Based Analysis

    Dec 1, 2025, 00:00

  • CO76 Does the Abortion Pill Harm Women? Serious Adverse Events Following Mifepristone Abortion in US Commercial and Medicaid Populations

    Dec 1, 2025, 00:00

  • EE625 Quantifying the Economic Burden of Osteoarthritis in Portugal: Insights From a Patient Journey Model

    Dec 1, 2025, 00:00

  • PCR188 Potential Impacts of Participating in an HIV Cure-Related Trial With an Analytical Treatment Interruption on Partners: Qualitative Research Findings

    Dec 1, 2025, 00:00

  • HPR213 The Role of Regulatory Entities in Global Vaccine Availability

    Dec 1, 2025, 00:00

  • CO86 Effectiveness of Pneumococcal Vaccines in Preventing Otitis Media in Children: A Targeted Literature Review

    Dec 1, 2025, 00:00

  • HTA272 Predicting SMC Appraisal Outcomes Using Machine Learning: A Model to Support Early Market Access Strategy

    Dec 1, 2025, 00:00

  • PT23 Optimizing Market Access in Europe: A Comparative Analysis of Submission Templates from the EU JCA and National HTA Bodies (HAS, G-BA, ZIN, DMC)

    Dec 1, 2025, 00:00

  • HTA60 Budget Impact Minimization Approaches Used Across Europe, Brazil, and Japan in the Reimbursement of Obesity Medications

    Dec 1, 2025, 00:00

  • EPH183 Postherpetic Neuralgia Occurrence and Herpes Zoster Recurrence in Immunocompromised Adults Aged 18 Years or Older in England: A Large Retrospective Cohort Study (Clinical Practice Research Datalink 2012-2019)

    Dec 1, 2025, 00:00

  • HSD7 Are Glucagon-Like Peptide-1 Receptor Agonists Prescribed for Weight Loss Slipping Through the Net of Japan’s Strict Guidelines? An Analysis of Health Insurance Claims Data

    Dec 1, 2025, 00:00

  • HPR3 A Comparative Analysis of Early Access Pathways in Italy and Fran Law 64896 vs. the French AAP

    Dec 1, 2025, 00:00

  • HTA327 The Preferences for Advanced Therapy Medicinal Products: A Multicriteria Decision Analysis Framework

    Dec 1, 2025, 00:00

  • PCR225 The Burden of Cognitive Impairment Associated With Schizophrenia (CIAS) on People With Lived Experience (PWLE): A National Canadian Survey

    Dec 1, 2025, 00:00

  • HPR116 Impact Of Reimbursement Policy On Medicines Expenditures And Copayment: The Case of Cardiovascular Medicines In Bulgaria

    Dec 1, 2025, 00:00

  • PT3 Radiographic Progression-Free Survival (rPFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Meta-Analysis and Surrogate Threshold Effect

    Dec 1, 2025, 00:00

  • RWD130 One Research Objective, Many Realities: Mapping Data Availability and Governance Diversity in Oncology Research

    Dec 1, 2025, 00:00

  • EE49 An Interactive R-Shiny Application for Budget Impact Modeling of Cell and Gene Therapies With Multiple Innovative Payment Scenarios

    Dec 1, 2025, 00:00

  • PCR210 Reliability Test of the Hungarian Versions of the Hypertension Knowledge Test and the QLICD-HY Quality of Life Assessment Questionnaire Among People With High Blood Pressure

    Dec 1, 2025, 00:00

  • EE606 Patient Blood Management With Intravenous Iron Is Economically Advantageous Compared to Usual Care in German Hospitals

    Dec 1, 2025, 00:00

  • MSR4 A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data

    Dec 1, 2025, 00:00

  • HTA97 Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions

    Dec 1, 2025, 00:00

  • PCR105 Health Equity in Economic Analyses of Person-Centered Care: A Systematic Review

    Dec 1, 2025, 00:00

  • CO90 Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

    Dec 1, 2025, 00:00

  • HTA150 From Evidence Gaps to Launch Delays: A Review of Health Technology Assessment Critiques and Health Economics and Outcomes Research Strategy Readiness

    Dec 1, 2025, 00:00

  • PCR208 Registry Participation in Rare Diseases: Insights from Stakeholders and an Adapted Targeted Literature Review (ATLR)

    Dec 1, 2025, 00:00

  • HTA308 Synthesizing Health Service Utilization Data for a Complex Intervention: A Case Study of Teledermatology

    Dec 1, 2025, 00:00

  • EE260 Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile

    Dec 1, 2025, 00:00

  • HTA234 Mind the Gap: Divergent Perceptions of Patient Engagement Value in Health Technology Assessment (HTA) Among Healthcare Providers and Patient Advocacy Groups in Israel

    Dec 1, 2025, 00:00

  • EE647 Relationship Between Cost-Effectiveness Threshold and Drug Reimbursement in Spain, Italy, and France

    Dec 1, 2025, 00:00

  • MSR93 Evaluating the Efficacy of Artificial Intelligence Models as Suitable Screening Tools in Systematic Reviews: The Example of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure Treatment

    Dec 1, 2025, 00:00

  • HTA174 Health Technology Assessment Landscape for Medical Devices in Europe

    Dec 1, 2025, 00:00

  • CO52 Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation

    Dec 1, 2025, 00:00

  • HTA141 Evolving Assumptions on Treatment Durability in Cost-Effectiveness Models of Cell and Gene Therapies: Insights From French HTA Submissions

    Dec 1, 2025, 00:00

  • HPR18 AI for Pricing Reimbursement: When to Green-Light, When to Red-Light?

    Dec 1, 2025, 00:00

  • P60 The Social Impact of Health (SIoH) Framework: Capturing How Health-Driven Productivity Shapes National Development

    Dec 1, 2025, 00:00

  • EE588 Modeling Framework for Assessing Cost-Effectiveness of New Treatments in Chronic Kidney Disease

    Dec 1, 2025, 00:00

  • RWD84 Feasibility Assessment of Real-World Data for Trial Emulations: A Methodological Framework

    Dec 1, 2025, 00:00

  • CO259 Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies

    Dec 1, 2025, 00:00

  • EPH78 Epidemiology and Demographic Characteristics of Phenylketonuria in Brazil: A Real-World Data Study (2019-2024)

    Dec 1, 2025, 00:00

  • EPH76 Epidemiological Insights in Merkel Cell Carcinoma Across Europe: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EPH8 A Retrospective Study of Treatment Use in Metastatic Colorectal Cancer (mCRC) Based on French Hospital Discharge Database

    Dec 1, 2025, 00:00

  • HTA273 Prefilled Syringes in Anesthesiology: A Quantitative Assessment of Economic and Organizational Outcomes

    Dec 1, 2025, 00:00

  • HTA277 Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?

    Dec 1, 2025, 00:00

  • EE51 Analysis of the Breast Cancer Diagnosis Program: A Window of Opportunity

    Dec 1, 2025, 00:00

  • EE661 Societal and Economic Impact of Targeted Therapy for Breast Cancer in Bulgaria

    Dec 1, 2025, 00:00

  • MSR18 AI Assistant Meets Human: Refining Methods for Research-Tailored AI Assistants to Support Global Product Strategy, Decision Making, and HEOR Impact

    Dec 1, 2025, 00:00

  • HPR203 The Impact of the COVID-19 Pandemic on the Performance of the Hospital Care System in Romania as Measured Using the Diagnosis-Related Groups (DRGs) Financing Technique

    Dec 1, 2025, 00:00

  • SA48 Graphical Evidence Frameworks to Visualize the Holistic Value of Healthcare Interventions

    Dec 1, 2025, 00:00

  • HPR228 Understanding the Impact of Cost-Effectiveness Evaluations on Drug Pricing in Japan: A Case Study of Oncology Therapies

    Dec 1, 2025, 00:00

  • MT10 Comparing Robotic-Assisted Coronary Artery Bypass Grafting Using the Da Vinci Surgical System to a Nonrobotic Approach: A Systematic Literature Review and Meta-Analysis

    Dec 1, 2025, 00:00

  • EE612 Potential Public Health Benefits of Recombinant Influenza Vaccines in Older Adults in England and Wales

    Dec 1, 2025, 00:00

  • PCR183 Patient-Reported Stigma Across Health Conditions: Insights From the National Health and Wellness Survey (NHWS) in China

    Dec 1, 2025, 00:00

  • P47 Quality of Life and Utility Values Across the Alzheimer’s Disease Spectrum: Results From the What Matters Most Survey

    Dec 1, 2025, 00:00

  • HSD64 Integrating CEUS in Diagnostic Pathways: Evidence of Economic and Organizational Sustainability From the Italian Healthcare System

    Dec 1, 2025, 00:00

  • EPH270 Unmet Need and the Public Health Grant: A Data-Driven Tool for Local Authority Spending Decisions

    Dec 1, 2025, 00:00

  • CO100 EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial

    Dec 1, 2025, 00:00

  • EE215 Cost-Effectiveness Analysis of Pediatric and Adult Pneumococcal Conjugate Vaccine Strategies in Canada

    Dec 1, 2025, 00:00

  • HSD53 From Diagnosis to Treatment: Evaluating Timeliness and Treatment Patterns in Czech Pancreatic Cancer Patients

    Dec 1, 2025, 00:00

  • CO51 Clinical Utility of Multiplex Point of Care (PCR) Compared to Antigen Testing for Influenza-Like Illness in the Hospital Emergency Department

    Dec 1, 2025, 00:00

  • HSD91 Rare Disease Awareness Among Physicians in Five European Countries: Results of a Cross-Sectional Survey

    Dec 1, 2025, 00:00

  • CO191 Prognostic Factor Evaluation for Clinical Outcomes in HER2-Mutant NSCLC

    Dec 1, 2025, 00:00

  • HTA184 HTA Conflicts in Europe: Agreeing to Disagree?

    Dec 1, 2025, 00:00

  • Disclosure Information

    Dec 1, 2025, 00:00

  • HSD99 Receipt of Biomarker Testing in Non-Small Cell Lung Cancer: Using Real-World Data to Identify Testing Gaps and Treatment Characteristics

    Dec 1, 2025, 00:00

  • EE42 The Value of Investing in Innovative Medicines: A Scalable Approach to Measure the Lifetime Social Impact

    Dec 1, 2025, 00:00

  • HTA115 Do Short-Term Outcome-Based Payments for Treatments Provide the Same Incremental Net Benefit As List Price Discounts?

    Dec 1, 2025, 00:00

  • MSR118 Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies

    Dec 1, 2025, 00:00

  • EE710 The Hidden Clinical and Economic Costs of PPI Treatment Failures in Severe Erosive Esophagitis

    Dec 1, 2025, 00:00

  • PCR100 From Pain to Patient Preferences Patient Engagement in Early HTA for Repurposing Losartan in Osteogenesis Imperfecta

    Dec 1, 2025, 00:00

  • EE490 Health Economic Assessment of Using Single-Operator Direct Visualization Cholangioscopy in the Management of Complex Bile Duct Stones in Saudi Arabia

    Dec 1, 2025, 00:00

  • MSR108 Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis

    Dec 1, 2025, 00:00

  • EE695 The Cost-Effectiveness of Using Site-Specific Wastewater-Based Surveillance to Monitor COVID-19 in Long-Term Care Facilities

    Dec 1, 2025, 00:00

  • SA4 A Systematic Literature Review of Prognostic Factors in Advanced Merkel Cell Carcinoma

    Dec 1, 2025, 00:00

  • HTA329 The Role of Environmental Evidence in HTA: Comparative Insights Into Global Assessment Frameworks

    Dec 1, 2025, 00:00

  • HTA344 Ukraine’s First Horizon Scanning Pilot: Lessons for HTA Implementation

    Dec 1, 2025, 00:00

  • HPR136 Mapping Access Pathways for New Medicines in Finland: A Real-World Review of HTA and Reimbursement Decisions

    Dec 1, 2025, 00:00

  • RWD140 Real-World Effectiveness of Immune Checkpoint Inhibitors Chemotherapy (ICI+CT) vs. ICI Monotherapy (ICI) in Untreated Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Targeted Literature Review

    Dec 1, 2025, 00:00

  • CO247 The Relationship Between Surrogate Endpoints and Overall Survival in Myelofibrosis Clinical Trials: Results From a Targeted Literature Review

    Dec 1, 2025, 00:00

  • EE346 Early Diagnosis and Treatment Optimization in Heart Failure Through NT-proBNP Testing in Primary and Specialist Care

    Dec 1, 2025, 00:00

  • EPH14 Analysis of a Cancer Profile of 10 European States

    Dec 1, 2025, 00:00

  • EE476 Forecasting the Rise in Direct and Indirect Costs for Lung Cancer on the Example of Poland

    Dec 1, 2025, 00:00

  • EE33 A Systematic Literature Review of Economic Evaluation Studies for Schizophrenia

    Dec 1, 2025, 00:00

  • MSR59 Comparing Key European HTA Body Methodological Standards for Systematic Reviews of Economic and Utility Evidence

    Dec 1, 2025, 00:00

  • RWD174 Signal Detection and Network Pharmacology Analysis of Paronychia Associated With eGFR Inhibitors

    Dec 1, 2025, 00:00

  • EE700 The Economic Burden of Inflammatory Arthritis: A Systematic Review

    Dec 1, 2025, 00:00

  • HTA359 What Are the Likely PICOs for Tovorafenib and Lifileucel as the First Products to Go Through the JCA?

    Dec 1, 2025, 00:00

  • PCR203 Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study

    Dec 1, 2025, 00:00

  • CO29 Biomarker Levels in Patients With Crohn’s Disease Post-Advanced Therapy Induction: A Real-World Survey in Europe

    Dec 1, 2025, 00:00

  • EPH163 Modeling the Public Health Impact of Nirsevimab and Maternal Vaccination With RSVpreF Against Infant Respiratory Syncytial Virus Infection in Germany

    Dec 1, 2025, 00:00

  • EE615 Price Behavior of Originator Adalimumab After Biosimilars Entry: Evidence From the Colombian Market

    Dec 1, 2025, 00:00

  • EE736 Treatment Patterns and Healthcare Resource Utilization in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in England: A Retrospective, Observational Cohort Study

    Dec 1, 2025, 00:00

  • EE531 Impact Of Dupilumab Treatment on Work-Related Medical Leave In Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study

    Dec 1, 2025, 00:00

  • EE338 Do Public Preferences Matter? Health-Economic Evaluation of Antineoplastic Medication Considering EQ-5D Value Sets From Several Countries

    Dec 1, 2025, 00:00

  • PCR125 Identifying Factors Associated With Involvement in Healthcare Decisions in Wales

    Dec 1, 2025, 00:00

  • HTA301 Stakeholder Involvement in the Health Technology Assessment Process in Ukraine

    Dec 1, 2025, 00:00

  • EE335 Disability-Associated Economic Burden Among Patients With Wilson’s Disease in South Korea: A Nationwide Cost-of-Illness Study

    Dec 1, 2025, 00:00

  • HTA293 Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease in Health Technology Assessment (HTA) Submissions Across EU4 + UK

    Dec 1, 2025, 00:00

  • HTA149 From Efficiency to Equity: Considerations in NICE Technology Appraisals

    Dec 1, 2025, 00:00

  • EE182 Cost of Treatment of Metastatic Non-Small Lung Cancer in Sweden, 2011-2023

    Dec 1, 2025, 00:00

  • MSR155 New Developments in the Psychometric Testing of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Questionnaire: Responsiveness and Minimally Important Change

    Dec 1, 2025, 00:00

  • P24 A Framework for Accelerating Clinical Development With Real-World External Control Arms (ECA) in Phase 2 Trials

    Dec 1, 2025, 00:00

  • EPH235 The Fiscal Case for Investing in COVID-19 Vaccination: A UK Treasury Perspective

    Dec 1, 2025, 00:00

  • CO17 Assessment of Newly Developed Medication Adherence Tool in Rural Community Pharmacies

    Dec 1, 2025, 00:00

  • MSR92 Evaluating the Conceptual Structure of the Barriers to Preexposure Prophylaxis (PrEP) Access Survey: A Confirmatory Item Factor Analysis

    Dec 1, 2025, 00:00

  • CO11 Antibody-Drug Conjugates in Colorectal Cancer: A Scoping Review of Current Evidence and Emerging Clinical Trends

    Dec 1, 2025, 00:00

  • EE109 Budget Impact of Introducing an Omalizumab Biosimilar in 23 European Countries

    Dec 1, 2025, 00:00

  • EE613 Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population

    Dec 1, 2025, 00:00

  • MT22 Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures

    Dec 1, 2025, 00:00

  • HPR109 Global Pricing Meets Domestic Policy: Analyzing the Financial Impact of the Most-Favored Nation Approach on the United States Medicine Prices

    Dec 1, 2025, 00:00

  • CO256 UDCA Treatment Response in Primary Biliary Cholangitis in the United States

    Dec 1, 2025, 00:00

  • PCR27 Association Between Subjective Sleep Quality and Quality of Life (QoL) Linked With Claims Data in the DeSC Healthcare Database in Japan

    Dec 1, 2025, 00:00

  • OP19 Qualitative Evaluation of an AI Tool for Opportunistic Detection of Vertebral Fractures in the National Health Service

    Dec 1, 2025, 00:00

  • HTA269 Paving the Path to Success for Joint Clinical Assessments: One Asset at a Time

    Dec 1, 2025, 00:00

  • EPH138 Important Risk Factors to Proxies of Treatment Failures in Patients With Major Depressive Disorder: Insights From a Claims Database Study

    Dec 1, 2025, 00:00

  • EPH30 Budget Impact of an Organized Colorectal Cancer Screening in High-Risk Populations in France

    Dec 1, 2025, 00:00

  • HTA83 Comparing Risk of Bias Assessment Requirements Between the EU JCA and European HTA Agencies

    Dec 1, 2025, 00:00

  • EPH255 The Role of Lifestyle in the Development of Fertility Issues

    Dec 1, 2025, 00:00

  • EPH266 Uncovering Gender Disparities in Secondary Care for Major Adverse Cardiovascular Events (MACE): Insights From the Hospital Episodes Statistics (HES) Database

    Dec 1, 2025, 00:00

  • HPR195 The Czech Republic’s Dedicated Orphan Drug Reimbursement Mechanism 2022-2025: Improvements in Access

    Dec 1, 2025, 00:00

  • EPH136 Impact of RSV Infection on Acute Otitis Media Burden in Young Children Beyond Their First Year of Life in Japan

    Dec 1, 2025, 00:00

  • CO257 Understanding XLH’s Impact: Incorporating Patient Perspectives to Develop a Comprehensive Conceptual Disease Model (CDM) to Drive Patient Engagement and the Generation of Meaningful Patient Experience Data

    Dec 1, 2025, 00:00

  • EE699 The Economic Burden of Diabetes-Related Blindness and Vision Impairment in Saudi Arabia

    Dec 1, 2025, 00:00

  • MSR109 Fitting Flexible Survival Models to Landmark Survival Estimates in R

    Dec 1, 2025, 00:00

  • EPH118 (HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)

    Dec 1, 2025, 00:00

  • EPH276 Utility Values for Dementia in Finland and Spain

    Dec 1, 2025, 00:00

  • HPR179 Rising Costs in Pharmaceutical Services: A Decade of Prescription Spending Trends in Türkiye 2015-2024

    Dec 1, 2025, 00:00

  • SA74 Patient Characteristics and Treatment Comparison Among Patients With Chronic Obstructive Pulmonary Disease: Real-World Evidence From Sweden

    Dec 1, 2025, 00:00

  • EE522 HPV-Related Disease Burden in Men and Women in the Czech Republic: A Claims Database Analysis

    Dec 1, 2025, 00:00

  • PCR173 Patient Perspectives on Disease Experiences and Value of Real-Time Self-Reported Symptom and Treatment Monitoring in Locally Advanced and Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • SA85 Simulating Patient Journeys in Heart Failure to Optimize Treatment Pathways: An Agent-Based Modeling Study

    Dec 1, 2025, 00:00

  • MSR170 Predicting PICOs Through Machine-Learning–Powered Information Compression and Statistical Ranking

    Dec 1, 2025, 00:00

  • SA51 Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey

    Dec 1, 2025, 00:00

  • EE254 Cost-Effectiveness of High-Dose vs. Adjuvanted Trivalent Influenza Vaccines in Older Adults in Korea

    Dec 1, 2025, 00:00

  • MSR124 How Publication Bias May Overestimate the Risk of Serious Adverse Events Associated With Bisphosphonate Use

    Dec 1, 2025, 00:00

  • EE298 Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction

    Dec 1, 2025, 00:00

  • OP15 Market Access AI Readiness: Maximizing Strategic Alignment Through Organizational Insights

    Dec 1, 2025, 00:00

  • P10 Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities From a Targeted Literature Review and Multi-Stakeholder Workshop

    Dec 1, 2025, 00:00

  • EE86 Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting

    Dec 1, 2025, 00:00

  • HTA140 Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis

    Dec 1, 2025, 00:00

  • Value-Based Commissioning of Mental Health Services in England: A Feasibility Study Using Multicriteria Decision Analysis

    Dec 1, 2025, 00:00

  • EE244 Cost-Effectiveness of Delgocitinib vs. PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema

    Dec 1, 2025, 00:00

  • HPR8 A Retrospective Analysis of Reimbursement Timelines in Ireland: What Does a 10-Year Analysis Show?

    Dec 1, 2025, 00:00

  • PT28 Cross-Validation of the Glycated Hemoglobin HbA1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs

    Dec 1, 2025, 00:00

  • EE337 Disease Management Costs in Late-Line Metastatic Colorectal Cancer: A Portuguese Perspective Using Structured Expert Elicitation

    Dec 1, 2025, 00:00

  • PCR78 Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study

    Dec 1, 2025, 00:00

  • HTA319 The Impact of Clinical Evidence on the Inclusion of Non-Small Cell Lung Cancer Drugs in Brazil's Supplementary Healthcare System

    Dec 1, 2025, 00:00

  • RWD131 Oracle Real-World Data: Analysis of the Characteristics and Representativeness of Oracle's Linked EHR-Claims Database

    Dec 1, 2025, 00:00

  • MSR56 Comparative Evaluation of Sequence-Encoding Strategies for Clustering Inhaled Therapy Pathways in COPD Patients Using Real-World Data

    Dec 1, 2025, 00:00

  • PCR252 Triangulation Method to Detect Meaningful Deterioration in Patient's Autonomy Using the New Multiple Sclerosis Autonomy Scale (MSAS) Questionnaire

    Dec 1, 2025, 00:00

  • CO30 Biomarker Levels in Patients With Ulcerative Colitis Post-Advanced Therapy Induction: A Real-World Survey in Europe

    Dec 1, 2025, 00:00

  • HTA144 Exploring Evidence Gaps in National Institute for Health and Care Excellence Early Value Assessments

    Dec 1, 2025, 00:00

  • RWD117 Leveraging Large Language Models and EMR Data to Identify Undiagnosed Rare Diseases: A Hybrid AI Approach

    Dec 1, 2025, 00:00

  • EPH41 Characteristics Associated With Having an Activity of Daily Living Limitation (ADLL) or Instrumental Activity of Daily Living Limitation (IADLL) Among US Adults With Asthma

    Dec 1, 2025, 00:00

  • CO42 Clinical and Economic Outcomes of Cannabis-Based Formulations (CBD and CBD/CBG) for Autism Spectrum Disorder (ASD): A HEOR Model Study Analysis

    Dec 1, 2025, 00:00

  • EPH145 Increases in Frailty Following Hospitalization With COVID-19: An Analysis of Claims and Annual Health Check Data

    Dec 1, 2025, 00:00

  • RWD65 Disease Management in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population

    Dec 1, 2025, 00:00

  • PCR128 Impact of Cancer on the Burden of Caregiving in China, Japan, and EU5: National Health and Wellness Survey

    Dec 1, 2025, 00:00

  • HTA256 NICE Technology Appraisal Submissions for Non-Small Cell Lung Cancer: Analysis and Insights

    Dec 1, 2025, 00:00

  • HSD87 Pharmacists’ Engagement With Pharmaceutical Care in Pakistan: Insights From a Cross-Sectional Survey on Knowledge, Attitudes, Practices, and Barriers

    Dec 1, 2025, 00:00

  • OP21 Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024

    Dec 1, 2025, 00:00

  • HSD72 Mapping the Landscape of Digital Healthcare Services Delivered by Specialized Oncology Hospitals in China: Qualitative Analytical Study

    Dec 1, 2025, 00:00

  • P50 Evaluating Personalized Care for Rare Disease: A Decision-Analytic Framework for Patient-Centered Solutions in Multiple System Atrophy

    Dec 1, 2025, 00:00

  • P58 An Evaluation Framework for Healthcare Professionals’ Digital Health and AI Technologies: Evidence-Based Policy Recommendations

    Dec 1, 2025, 00:00

  • EE744 Unlocking Value: Assessing the Cost-Effectiveness of Pitolisant Wakix®in Portugal

    Dec 1, 2025, 00:00

  • HSD3 Access to Decide on a Generalization: Results From the EVA-Corse Experiment: Efficiency and Clinical Non-Inferiority of a Hybrid Cardiac Rehabilitation Model in Corsica

    Dec 1, 2025, 00:00

  • RWD175 Study Design Trends in Registry-Based Oncology Studies: Analysis of HMA-EMA Real-World Data Catalogs

    Dec 1, 2025, 00:00

  • CO137 Impact of Disease Progression on Healthcare Resource Utilization and Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey

    Dec 1, 2025, 00:00

  • P2 Can AI-Assisted Data Extraction From HTA Reports Improve Comparative HTA Research: A Case Study on NICE Assessment Reports

    Dec 1, 2025, 00:00

  • EE207 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 1 Diabetes in Sweden: A National Real-World Evidence Perspective

    Dec 1, 2025, 00:00

  • EE35 A Systematic Review of the Methods and Quality of Economic Evaluations for AI-Assisted Cancer Screening or Diagnosis

    Dec 1, 2025, 00:00

  • RWD91 Healthcare Resource Use Among Children With Mucopolysaccharidosis Type III MPS III: A Retrospective Claims Database Analysis in the US

    Dec 1, 2025, 00:00

  • SA18 Calibrating Large Language Model Probabilities to Achieve Target Recall in Systematic Review Screening

    Dec 1, 2025, 00:00

  • EPH147 Inequality in Vaccine Uptake: Lessons Learned From Denmark Analyzing Real-World Data From National Registries

    Dec 1, 2025, 00:00

  • HPR1 ComboConnect—Bridging Access Gaps in Combination Therapies: An Italian Project in Collaboration With ISPOR Italy-Rome Chapter

    Dec 1, 2025, 00:00

  • MSR135 Key Risk Indicators in eCOA: Considerations for Improving eDiary Data Quality and Regulatory Compliance

    Dec 1, 2025, 00:00

  • P43 Cost-Effectiveness and Budget Impact of Gene Therapy for Eligible Patients With Sickle Cell Disease in the Netherlands

    Dec 1, 2025, 00:00

  • EE723 The Societal Value of Lecanemab for Patients With Early Alzheimer's Disease in Japan

    Dec 1, 2025, 00:00

  • CO58 Comparative Efficacy of Iptacopan Monotherapy vs. Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC)

    Dec 1, 2025, 00:00

  • MSR166 Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD)

    Dec 1, 2025, 00:00

  • EE41 Adjuvanted RSVpreF3 Vaccine for Respiratory Syncytial Virus Prevention in the United Kingdom, Spain, and Australia: A Climate Change Impact Analysis

    Dec 1, 2025, 00:00

  • EE626 Quantifying the Economic Impact of Flexible Endoscope-Related Procedure Rescheduling in NHS Endoscopy Services: A Retrospective Analysis and Survey-Based Model

    Dec 1, 2025, 00:00

  • HPR198 The Effect of Pharmaceutical Pricing Policies on Healthcare Expenditures in Turkey: Analysis for the Period 2015-2024

    Dec 1, 2025, 00:00

  • P18 Mixed-Method Exploration of Visual Analogue Scale (VAS) Variations to Measure Health, Social Care, and Carer-Related Quality of Life (QoL)

    Dec 1, 2025, 00:00

  • EE545 Impacts of National Medical Insurance Negotiation on Antitumor Drug Utilization and Financial Burden: A City-Level Analysis in China

    Dec 1, 2025, 00:00

  • MSR136 Leveraging Generative Artificial Intelligence for the Creation of Global Value Dossiers Through a RAG Pipeline and Multi-Agent Integration

    Dec 1, 2025, 00:00

  • PT15 Development of the Eating Drivers Diary (EDDY): A Novel Patient-Reported Outcome Measure for Use in Clinical Trials of Medications for Weight Reduction

    Dec 1, 2025, 00:00

  • RWD82 Expediting Oncology Evidence Generation by Leveraging EMR-Enabled Clinically Rich Real-World Data at Scale

    Dec 1, 2025, 00:00

  • HPR45 Clinical Outcome Assessments in Drug Approvals: Trends and Insights From FDA; EMA Labeling 2018-2023

    Dec 1, 2025, 00:00

  • HSD32 Describing the Real-World Burden of Demodex Blepharitis: A Multicenter Audit in a UK Public Specialist Eye-Care Setting

    Dec 1, 2025, 00:00

  • EE89 Budget Impact Analysis of Introducing Nirsevimab Into the National Immunization Program for Infants in Korea

    Dec 1, 2025, 00:00

  • EE183 Cost per Responder Analysis of Bimekizumab, a Monoclonal IgG1 Antibody Which Selectively Inhibits Il17f in Addition to Il17a Against Il17a Inhibitors in the Treatment of Axial Spondyloarthritis in Finland

    Dec 1, 2025, 00:00

  • EE524 Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost

    Dec 1, 2025, 00:00

  • SA25 Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)

    Dec 1, 2025, 00:00

  • EPH219 Strong But Do They Ask for Help? Mental Health of Young Athletes

    Dec 1, 2025, 00:00

  • P14 Cost-Effectiveness Modeling of Test and Treat Strategies: A Diagnosis of Over-Complexity

    Dec 1, 2025, 00:00

  • EPH7 A Real-World Survey of Health Inequalities as Drivers for Burden on Male Hemophilia Patients in the US, EU5, and Asia

    Dec 1, 2025, 00:00

  • RWD114 Late Treatment in Adults With Neurogenic Bowel Dysfunction: A Retrospective Analysis of German Claims Data

    Dec 1, 2025, 00:00

  • PT38 Efficacy and Safety of Nalbuphine Compared With Analgesics for Moderate to Severe Postoperative Pain: A Systematic Review and Network Meta-Analysis

    Dec 1, 2025, 00:00

  • EPH84 Estimated Healthcare Resource Utilization and Costs Associated With Semaglutide Life Expectancy Gains in a Real-World Population With CVD and Overweight or Obesity in the United Kingdom

    Dec 1, 2025, 00:00

  • PCR54 Cross-Country Comparison of Cancer-Related Health Preferences Using the EORTC QLU C10D: Evidence Supporting Standardized Value Sets

    Dec 1, 2025, 00:00

  • EE663 Societal Impact Analysis of Introducing Elexacaftor Tezacaftor Ivacaftor (ELX TEZ IVA) in the Management of People With Cystic Fibrosis in Germany: A Paid and Unpaid Work Productivity Approach

    Dec 1, 2025, 00:00

  • HTA125 Ensuring Greater Acceptance of Minimal Residual Disease Negativity in Health Technology Assessments in Multiple Myeloma: Key Barriers and Opportunities

    Dec 1, 2025, 00:00

  • CO210 Reducing Healthcare Costs and Addressing Health Equity Through Improved Treatment Adherence and Reduced Exacerbation Risk in Chronic Obstructive Pulmonary Disease: Real-World Evidence From a Danish Nationwide Cohort Study

    Dec 1, 2025, 00:00

  • EE80 Budget Impact Analysis of 68-Ga-PSMA-11 PET CT Imaging Followed by 177Lu-PSMA-617 Therapy in Metastatic Castrate-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • HTA34 Analytical Modeling in Economic Evaluations of Obesity Interventions to Inform Health Policy: A Narrative Review

    Dec 1, 2025, 00:00

  • SA45 Gaps in JCA Guidance for Systematic Literature Reviews: A Comparative Review with Cochrane, EUnetHTA, and Major HTA Agencies' Standards

    Dec 1, 2025, 00:00

  • PCR1 Too Good to Be True? Social Desirability Bias in Age-Related Patterns of Self-Reported Medication Adherence Among Patients With Atrial Fibrillation

    Dec 1, 2025, 00:00

  • HTA35 Applicability of the STEDI Value Framework to Vaccines in Health Technology Assessment: Opportunities and Considerations

    Dec 1, 2025, 00:00

  • HTA42 Artificial Intelligence in Pharmaceutical Payer Decision Making—Assessing Current Use, Strategic Intent, and Infrastructure Readiness

    Dec 1, 2025, 00:00

  • HTA369 Who Speaks For Europe? A Country-Level Analysis Of Representation And Expertise In EU Health Technology Assessment Joint Bodies

    Dec 1, 2025, 00:00

  • EE141 Comparing Alternative Extrapolation Methods Using Standard Partitioned Survival Model Functionality in the Presence of Converging Survival Data: A Case Study in Renal Cell Carcinoma

    Dec 1, 2025, 00:00

  • CO141 Impact of Prenatal Exposure to Antidepressants on Adverse Birth and Pregnancy Outcomes: A Propensity-Scored Matched Retrospective Cohort Study Using a Large Electronic Medical Record Database 2012-2021

    Dec 1, 2025, 00:00

  • HTA88 Confidential Prices in NICE Health Technology Assessment: How Common Are They?

    Dec 1, 2025, 00:00

  • SA71 Natural Language Processing for Identification of Negative Symptoms in Patients With and Without Cognitive Impairment Associated With Schizophrenia (CIAS)

    Dec 1, 2025, 00:00

  • HPR220 Towards Shaping Rare Diseases and Orphan Drugs Health Ecosystem in Saudi Arabia

    Dec 1, 2025, 00:00

  • PT34 A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Gree Proposal for a Medicines Innovation Fund

    Dec 1, 2025, 00:00

  • MSR218 Validating the Use of Large Language Models to Generate Individual Patient-Level Data for Use in Health Technology Assessment

    Dec 1, 2025, 00:00

  • RWD157 Real-World Evidence Study on PD-L1 Testing and Use of Immuno-Oncology (IO) Treatments Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland

    Dec 1, 2025, 00:00

  • EE273 Cost-Effectiveness of Rozanolixizumab vs. Efgartigimod in the Treatment of Generalized Myasthenia Gravis (gMG) in Greece

    Dec 1, 2025, 00:00

  • EPH104 Exploring Factors Associated With Online Food Delivery Behavior Among Young Adults

    Dec 1, 2025, 00:00

  • HTA261 Organizational Readiness for EU HTA: Early Learnings and Key Considerations for Successful Market Access

    Dec 1, 2025, 00:00

  • PCR264 Variability in Health Utility Scores in Pancreatic Cancer: Findings From a Targeted Literature Review

    Dec 1, 2025, 00:00

  • HPR214 The Role of Technological Innovation and Policy in the Evolution of Care Models in Italy

    Dec 1, 2025, 00:00

  • OP20 Qualitative Insights Into Artificial Intelligence (AI) and Virtual Reality (VR) Training for Value Communication: Comparing Innovative Technologies With Traditional Methods in Pharma

    Dec 1, 2025, 00:00

  • HTA209 Integrating Real-World Evidence Into Oncology HTA Submissions: Recent EU Examples

    Dec 1, 2025, 00:00

  • PCR241 The Reliability and Validity of the Greek Version of the Pediatric Quality of Life Inventory™ 30 Duchenne Muscular Dystrophy Module in Children With Duchenne Muscular Dystrophy

    Dec 1, 2025, 00:00

  • PCR255 Understanding Treatment Preference Heterogeneity in Psoriasis: Insights From a Qualitative Analysis of Social Media Data

    Dec 1, 2025, 00:00

  • HTA85 Competing Beyond the First Mover: How Late to Market Analogues Navigate Pricing and Access in Major Global Markets

    Dec 1, 2025, 00:00

  • PCR139 Informing Health System Reform Through Patient Perspectives: Saudi Arabia’s OECD Paris Survey Results

    Dec 1, 2025, 00:00

  • HTA101 Cross-Agency Analysis of Six-Minute Walk Test (6MWT) Adoption in Muscular and Nonmuscular Neurological HTA Submissions: Assessing Surrogate Endpoints for Disease Progression

    Dec 1, 2025, 00:00

  • RWD77 Evaluating a Potential Link Between Alprazolam and Intracranial Aneurysm: A Pharmacovigilance and Bioinformatics Approach Through FAERS and Molecular Docking

    Dec 1, 2025, 00:00

  • HPR175 Resilient Pharmaceutical Supply Chains in Times of Crisis: A Comparative Analysis of Australia, France, Italy, Spain, and UK

    Dec 1, 2025, 00:00

  • HPR78 Evaluation of the Implementation Effect of Medical Service Price Reforms: A Case Study of Assisted Reproductive Services in China

    Dec 1, 2025, 00:00

  • HPR189 Stakeholder Mapping and Policy Assessment of Rare Diseases in Southeast Asia

    Dec 1, 2025, 00:00

  • HSD84 Patterns of Treatment Adherence and Administration Preferences for People With Transthyretin Amyloid Cardiomyopathy: A Real-World Survey in Europe, the United States, and Japan

    Dec 1, 2025, 00:00

  • EPH120 Healthcare Pathway of a Large Cohort of Patients With Chronic Obstructive Pulmonary Disease During the Last Year of Life

    Dec 1, 2025, 00:00

  • RWD79 Evaluation of Real-World Data Landscape in the United Kingdom: A Scoping Review

    Dec 1, 2025, 00:00

  • EE403 Economic Modeling in Ophthalmology: Reimagining Cost-Effectiveness Model Structures

    Dec 1, 2025, 00:00

  • EPH258 Treatment Patterns in Epithelial Ovarian Cancer (EOC) With a Focus on Recurrent EOC and PARPi Progressors: A Targeted Literature Review Across Selected Countries

    Dec 1, 2025, 00:00

  • MSR219 Variations in Mortality Across Clinical Trials: A Review of Statistical Methods for Adjusting for the Effect of the COVID-19 Pandemic

    Dec 1, 2025, 00:00

  • HTA127 Equality Considerations in NICE Guidance of Medical Devices Digital and Diagnostic Technologies and Interventional Procedures

    Dec 1, 2025, 00:00

  • HTA143 Examining the Relationship Between the NICE WTP Threshold and the Severity Modifier

    Dec 1, 2025, 00:00

  • EE355 Economic Burden Associated With Type 2 Diabetes Mellitus in Fran An Update From the National Insurance Claim Database

    Dec 1, 2025, 00:00

  • MSR162 PACE in Scotland: Utilizing Machine Learning to Assess the Importance of Patient and Clinician Engagement in HTAs in SMC

    Dec 1, 2025, 00:00

  • HSD47 Evaluating the Validity of Immunotherapy in Retreatment and Rechallenge Strategies for Oncology Patients

    Dec 1, 2025, 00:00

  • EE330 Dihydropyrimidine Dehydrogenase (DPYD) Genetic Testing Before Fluoropyrimidine-Based Adjuvant Chemotherapy for Colorectal Cancer in Qatar: A Cost-Effective Approach

    Dec 1, 2025, 00:00

  • RWD41 Comparing the Addition of Natural Language Processing (NLP) to US Electronic Health Records (EHRs): Insights Into Extracting Predicted Forced Vital Capacity (PpFVC) From Unstructured Clinical Notes

    Dec 1, 2025, 00:00

  • EPH176 Persistence With Antidementia Therapy in Germany: A Retrospective Cohort Study of 212,850 Patients

    Dec 1, 2025, 00:00

  • EE212 Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile

    Dec 1, 2025, 00:00

  • SA87 Systematic Literature Review SLR Characterizing Humanistic Disease Burden and Unmet Needs in Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)

    Dec 1, 2025, 00:00

  • HTA4 A Comprehensive Review of Health Technology Reassessments for Oncology Drugs in Fran Impact on Reimbursement Outcomes 2019-2024

    Dec 1, 2025, 00:00

  • EE465 Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States

    Dec 1, 2025, 00:00

  • PT2 Frequency and Impact of External Comparator Arms in Oncology HTA Assessments With Single-Arm Trials in the UK, France, and Germany From 2014 to 2024

    Dec 1, 2025, 00:00

  • P29 Do Older People Always Prefer Avoiding Nursing Homes? Evidence in France From a Mixed-Methods Approach

    Dec 1, 2025, 00:00

  • CO33 Bridging the Regulatory-Payer Evidence Gap: A Case Study With Six Minute Walk Distance and Mortality

    Dec 1, 2025, 00:00

  • EE145 Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion

    Dec 1, 2025, 00:00

  • PT11 High Entry Costs Slower Growth: A Nationwide Register Study on Newly Reimbursed Biologic Medicines in Finland 2011-2021

    Dec 1, 2025, 00:00

  • EE575 Medicare Reimbursements Following Confirmatory MRI-Guided Biopsy vs. Systematic Biopsy Only in Low-Risk and Favorable Intermediate-Risk Prostate Cancer: A Real-World Cost Analysis Among Elderly Medicare Beneficiaries

    Dec 1, 2025, 00:00

  • PCR165 Navigating Uncertainty and Pragmatic Acceptan Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health

    Dec 1, 2025, 00:00

  • EE60 Assessing the Cost-Effectiveness of Subcutaneous Semaglutide 2.4 mg in the Management of Individuals With Obesity and Prediabetes in England

    Dec 1, 2025, 00:00

  • HSD1 A Case Study Demonstrating the Utility of the High-Tech Hub Electronic Prescribing Facility to Identify Off-Label Prescribing

    Dec 1, 2025, 00:00

  • EPH161 Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective

    Dec 1, 2025, 00:00

  • EPH222 Suicide in Prehospital Practice

    Dec 1, 2025, 00:00

  • CO69 Delphi Panel for Standardizing Outcome Measures in Radical Prostatectomy Surgical Care Pathway

    Dec 1, 2025, 00:00

  • EPH152 Ischemic Stroke in Europe: Incidence Trends Over Three Decades (1991-2021)

    Dec 1, 2025, 00:00

  • RWD49 Data Linkage in Practi A Living Systematic Review of Clinical Trials in the United States (US) Utilizing Linkage to Real-World Data

    Dec 1, 2025, 00:00

  • EE745 Unveiling the Economic Landscape: Burden of HR/HER2 Locally Recurrent Inoperable or Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • EE734 Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder

    Dec 1, 2025, 00:00

  • HPR226 Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications

    Dec 1, 2025, 00:00

  • PCR6 A Methodological Review of WOMAC to EQ-5D Mapping Algorithms in Knee Osteoarthritis

    Dec 1, 2025, 00:00

  • MSR113 From Unstructured Text to Enriched Data: Evaluating Large Language Models for Clinical Information Extraction From Echocardiogram Reports

    Dec 1, 2025, 00:00

  • HPR196 The Development of the Private Healthcare Sector in Romania Between 2005 and 2023

    Dec 1, 2025, 00:00

  • HTA20 Activity of the French Economic and Public Health Evaluation Committee (CEESP): Retrospective of 10 Years of Economic Assessment on Health Products

    Dec 1, 2025, 00:00

  • EE454 Experience of Single Dose IV Iron (Ferric Derisomaltose) Use in a Rural District General Medicine Ambulatory Unit and Overview of Its Economic and Sustainability Impact

    Dec 1, 2025, 00:00

  • EPH232 The Cost of Inaction: Strengthening Nutrition in Frailty Guidelines Across Europe

    Dec 1, 2025, 00:00

  • HTA229 Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan

    Dec 1, 2025, 00:00

  • HSD60 Humanistic and Financial Burden Experienced by Nonprofessional Care Partners of Patients With Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease: Results From a Real-World Survey in Spain

    Dec 1, 2025, 00:00
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »